Filing Details
- Accession Number:
- 0000899243-22-027415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-02 17:26:40
- Reporting Period:
- 2022-08-01
- Accepted Time:
- 2022-08-02 17:26:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1613498 | Jon Snodgres | C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-08-01 | 2,000 | $220.00 | 37,187 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022.
Billionaire Hedge Funds
